A resolution recognizing and supporting individuals born with congenital disabilities or malformations due to thalidomide exposure.
Latest Action
Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S3893-3894)
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™Senate Resolution 714 of the 118th Congress is a non-binding resolution recognizing and supporting individuals born with congenital disabilities or malformations attributed to thalidomide exposure. The resolution aims to acknowledge the challenges faced by these individuals and express support for their well-being. The bill was referred to the Senate Committee on Health, Education, Labor, and Pensions but did not advance further and is currently classified as failed or expired. No legislative text or detailed provisions are publicly available for this resolution.
S.Res. 714 is a symbolic resolution intended to recognize and support people affected by thalidomide-related birth defects, but it contains no enforceable provisions and did not progress beyond committee referral.
- The resolution focuses on individuals born with congenital disabilities or malformations due to thalidomide exposure.
- It is a Senate resolution, which typically expresses the sentiment or position of the Senate without creating binding law.
- The bill was referred to the Senate Committee on Health, Education, Labor, and Pensions on May 23, 2024, but did not advance and is now failed or expired.
['Individuals born with congenital disabilities or malformations linked to thalidomide exposure', 'Advocacy groups focused on congenital disabilities and pharmaceutical safety', 'Public health and medical communities concerned with birth defect awareness']
['As a non-binding resolution, it does not provide direct funding or legal remedies for affected individuals.', 'Lack of detailed provisions or implementation mechanisms limits practical impact.', "No oversight or enforcement mechanisms are included due to the resolution's symbolic nature."]
The resolution was introduced in the Senate during the 118th Congress and referred to the Committee on Health, Education, Labor, and Pensions. It reflects ongoing congressional recognition of historical pharmaceutical impacts on public health. The resolution did not proceed beyond committee referral and is now classified as failed or expired, indicating limited legislative momentum or priority.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['May increase public and legislative awareness of thalidomide-related congenital disabilities.', 'Could encourage future legislative or policy initiatives addressing pharmaceutical safety and support for affected individuals.', 'Symbolic recognition might support advocacy efforts even without direct legal impact.']
The resolution's lack of binding authority and absence of detailed text limit its direct policy impact. Transparency is constrained by missing full bill text and summary, which restricts comprehensive public and legislative scrutiny. Monitoring similar future measures for inclusion of enforceable provisions and funding is advisable.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.